BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair
- PMID: 10373498
- DOI: 10.1074/jbc.274.26.18808
BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair
Abstract
The breast cancer predisposition genes, BRCA1 and BRCA2, are responsible for the vast majority of hereditary breast cancer. Although BRCA2 functions to help the cell repair double-stranded DNA breaks, the function of BRCA1 remains enigmatic. Here, we develop a human genetic system to study the role of BRCA1 in oxidative DNA damage. We show that human cancer cells containing mutated BRCA1 are hypersensitive to ionizing radiation. This hypersensitivity can be reversed by the expression of forms of BRCA1 that are not growth suppressing. Reversal of hypersensitivity requires the ring finger of BRCA1, its transactivation domain, and its BRCT domain. Lastly, we show that unlike BRCA2, BRCA1 does not function in the repair of double-stranded DNA breaks. Instead, it functions in transcription-coupled DNA repair (TCR). TCR ability correlated with radioresistance as cells containing BRCA1 showed both increased TCR and radioresistance, whereas cells without BRCA1 showed decreased TCR and radiosensitivity. These findings give physiologic significance to the interaction of BRCA1 with the basal transcription machinery.
Similar articles
-
Genetic analysis of BRCA1 function in a defined tumor cell line.Mol Cell. 1999 Dec;4(6):1093-9. doi: 10.1016/s1097-2765(00)80238-5. Mol Cell. 1999. PMID: 10635334
-
FOXP3 regulates sensitivity of cancer cells to irradiation by transcriptional repression of BRCA1.Cancer Res. 2013 Apr 1;73(7):2170-80. doi: 10.1158/0008-5472.CAN-12-2481. Epub 2013 Jan 14. Cancer Res. 2013. PMID: 23319807 Free PMC article.
-
Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.Cancer Res. 2001 Jan 1;61(1):270-7. Cancer Res. 2001. PMID: 11196174
-
Therapeutic exploitation of tumor cell defects in homologous recombination.Anticancer Agents Med Chem. 2008 May;8(4):448-60. doi: 10.2174/187152008784220267. Anticancer Agents Med Chem. 2008. PMID: 18473729 Review.
-
Chromosomal mutagen sensitivity associated with mutations in BRCA genes.Cytogenet Genome Res. 2004;104(1-4):325-32. doi: 10.1159/000077511. Cytogenet Genome Res. 2004. PMID: 15162060 Review.
Cited by
-
Haberlea rhodopensis Extract Tunes the Cellular Response to Stress by Modulating DNA Damage, Redox Components, and Gene Expression.Int J Mol Sci. 2023 Nov 4;24(21):15964. doi: 10.3390/ijms242115964. Int J Mol Sci. 2023. PMID: 37958947 Free PMC article.
-
The contribution of inherited factors to the clinicopathological features and behavior of breast cancer.J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):453-65. doi: 10.1023/a:1014791115760. J Mammary Gland Biol Neoplasia. 2001. PMID: 12013534 Review.
-
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.Genes Dev. 2000 Apr 15;14(8):927-39. Genes Dev. 2000. PMID: 10783165 Free PMC article.
-
Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5134-9. doi: 10.1073/pnas.081068398. Proc Natl Acad Sci U S A. 2001. PMID: 11320250 Free PMC article.
-
Controversial BRCA1 allelotypes in commonly used breast cancer cell lines.Breast Cancer Res Treat. 2010 Jan;119(1):249-51. doi: 10.1007/s10549-009-0465-3. Epub 2009 Jul 8. Breast Cancer Res Treat. 2010. PMID: 19585236 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous